Terumo's Cross-Seal Suture-Mediated Vascular Closure Device System Studied in IDE Trial

November 4, 2022—The objective of the prospective, multicenter, single-arm Cross-Seal investigational device exemption (IDE) trial was to determ

Related Keywords

Nevada ,United States ,Prakash Krishnan ,Las Vegas ,Foundation On ,Terumo Interventional Systems ,Late Breaking Clinical Trials ,Viva22 ,Bct ,Across Seal ,Dude ,Investigational Device Exemption ,Cd ,Hemostasis ,Tavr ,Bulevar ,Var ,Balloon Aortic Valvuloplasty ,Ith ,